HOXC10 and colorectal carcinoma: To investigate the underlying mechanism of the antitumor response triggered by the combination of SB225002 and anti-PD-L1 antibody, we analyzed the infiltration of MDSCs and CD8+T cells in MC38-HOXC10 orthotopic CRC tumors by IHC.